Mahamaya Lifesciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	3,289	2,641	1,616	1,371	899.13
Other Revenue	11.59	0.87	-	0.45	0.05
Revenue	3,300	2,642	1,616	1,371	899.19
Revenue Growth (YoY)	24.90%	63.54%	17.83%	52.50%	-
Cost of Revenue	2,748	2,267	1,391	1,184	752.95
Gross Profit	551.93	374.97	224.48	186.77	146.24
Selling, General & Admin	82.93	78.2	54.06	50.79	55.4
Other Operating Expenses	126.38	49.54	36.39	38.95	26.62
Operating Expenses	231.72	145.46	104.51	102.46	91.62
Operating Income	320.21	229.51	119.96	84.31	54.62
Interest Expense	-81.39	-55.12	-46.04	-26.33	-15.8
Interest & Investment Income	-	2.66	3.22	0.78	0.33
Currency Exchange Gain (Loss)	-	9.1	4.56	-5.88	0.1
Other Non Operating Income (Expenses)	-	-12.72	-9.18	-2.13	-2.03
EBT Excluding Unusual Items	238.82	173.43	72.52	50.76	37.21
Gain (Loss) on Sale of Assets	-	0.19	0.18	0.21	-
Other Unusual Items	-0.04	-1.1	1.58	-	-
Pretax Income	238.78	172.52	74.28	50.96	37.21
Income Tax Expense	73.54	44.4	20.52	13.46	9.98
Net Income	165.23	128.12	53.76	37.51	27.23
Net Income to Common	165.23	128.12	53.76	37.51	27.23
Net Income Growth	28.97%	138.31%	43.34%	37.72%	-
Shares Outstanding (Basic)	20	17	14	14	14
Shares Outstanding (Diluted)	20	17	14	14	14
Shares Change (YoY)	16.82%	23.62%	-	-	-
EPS (Basic)	8.33	7.55	3.91	2.73	1.98
EPS (Diluted)	8.33	7.55	3.91	2.73	1.98
EPS Growth	10.40%	92.78%	43.36%	37.88%	-
Free Cash Flow	-383.32	-83.49	-249.73	-17.7	-11.07
Free Cash Flow Per Share	-19.32	-4.92	-18.18	-1.29	-0.81
Gross Margin	16.72%	14.19%	13.89%	13.62%	16.26%
Operating Margin	9.70%	8.69%	7.42%	6.15%	6.08%
Profit Margin	5.01%	4.85%	3.33%	2.73%	3.03%
Free Cash Flow Margin	-11.62%	-3.16%	-15.46%	-1.29%	-1.23%
EBITDA	342.63	242.43	129.58	92.78	62.85
EBITDA Margin	10.38%	9.18%	8.02%	6.77%	6.99%
D&A For EBITDA	22.42	12.92	9.62	8.46	8.22
EBIT	320.21	229.51	119.96	84.31	54.62
EBIT Margin	9.70%	8.69%	7.42%	6.15%	6.08%
Effective Tax Rate	30.80%	25.74%	27.63%	26.40%	26.82%
Revenue as Reported	3,300	2,672	1,628	1,374	901.56

Source: S&P Global Market Intelligence. Standard template. Financial Sources.